[Comparison of an ionic (ioglicinate) with a non-ionic (iohexol) contrast medium in renal computed tomography]. 1986

F Weigert, and A Hartmann, and U Rohde

UI MeSH Term Description Entries
D007463 Iodobenzoates Benzoic acid esters or salts substituted with one or more iodine atoms. Iodobenzoic Acids,Acids, Iodobenzoic
D007472 Iohexol An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Compound 545,Exypaque,Iohexol 350,Nycodenz,Omnipaque
D007483 Iothalamic Acid A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts. Iotalamic Acid,Methalamic Acid,Angio-Conray,Conray 420,Iodothalamate,Iothalamate,Iothalamic Acid, Calcium (2:1) Salt,Iothalamic Acid, Monosilver (1+) Salt,Iothalamic Acid, Monosodium Salt,Iothalamic Acid, Monosodium Salt, Dimer,Lopamidol,Sodium Iothalamate,Acid, Iotalamic,Acid, Iothalamic,Acid, Methalamic,Angio Conray,AngioConray,Iothalamate, Sodium
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

F Weigert, and A Hartmann, and U Rohde
January 1983, AJNR. American journal of neuroradiology,
F Weigert, and A Hartmann, and U Rohde
April 1984, Rinsho hoshasen. Clinical radiography,
F Weigert, and A Hartmann, and U Rohde
February 1989, Wiener medizinische Wochenschrift (1946),
F Weigert, and A Hartmann, and U Rohde
January 1984, Acta radiologica: diagnosis,
F Weigert, and A Hartmann, and U Rohde
January 1999, Journal of the Indian Medical Association,
F Weigert, and A Hartmann, and U Rohde
January 1980, Acta radiologica. Supplementum,
F Weigert, and A Hartmann, and U Rohde
January 1983, Acta radiologica. Supplementum,
F Weigert, and A Hartmann, and U Rohde
August 1993, Hinyokika kiyo. Acta urologica Japonica,
Copied contents to your clipboard!